Atlas Trials

Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus

Clinical trial NCT01472185 · COMPLETED

Trial details

NCT number
NCT01472185
Sponsor
Gilead Sciences
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2011-11-01
Primary completion
2013-10-01
Enrollment
465

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.